Future Drug Discovery Author Guidelines

Future Drug Discovery Author Guidelines

Version: 17/10/2018 Future Drug Discovery Author Guidelines This document outlines how to prepare articles for submission. We recommend you read these guidelines in full before submitting your article or making an article proposal. Table of Contents Journal aims & scope ............................................................................................................................... 4 Audience .................................................................................................................................................. 4 At-a-glance article formatting checklist................................................................................................... 5 Search engine optimization ..................................................................................................................... 6 Article types ............................................................................................................................................. 7 Original Research Articles .................................................................................................................... 7 Reviews ................................................................................................................................................ 9 Perspectives ......................................................................................................................................... 9 Special Reports .................................................................................................................................... 9 Editorials .............................................................................................................................................. 9 Commentaries...................................................................................................................................... 9 Conference Reports ............................................................................................................................. 9 Interviews ..........................................................................................................................................10 Company/Institutional Profiles ..........................................................................................................10 Article sections .......................................................................................................................................10 Title ....................................................................................................................................................10 Author(s) names & affiliations ...........................................................................................................10 Author Contributions .........................................................................................................................10 Abstract ..............................................................................................................................................10 Structured abstract (for research articles) ........................................................................................10 Future Science Ltd, Unitec House, 2 Albert Place, London, N3 1QB, UK; T: +44 (0)20 8371 6090; F: +44 (0)20 8371 6089; www.future-science.com Future Science Ltd is part of the Future Science Group www.future-science-group.com Version: 17/10/2018 Lay Abstract .......................................................................................................................................11 Keywords ...........................................................................................................................................11 Body of the article..............................................................................................................................11 Future Perspective .............................................................................................................................11 Executive Summary ...........................................................................................................................11 Accession Numbers............................................................................................................................11 Financial disclosure/Acknowledgements ..........................................................................................11 Ethical conduct of research ...............................................................................................................11 References .............................................................................................................................................12 Making the most of article abstracts .....................................................................................................13 Graphical abstracts ............................................................................................................................13 Figures, tables, boxes & supplementary files (incl. video) ....................................................................16 Chemical structures ...........................................................................................................................17 Electronic files ....................................................................................................................................17 Copyright............................................................................................................................................17 Supplementary materials, including videos ......................................................................................18 Units of measurement ...........................................................................................................................19 Statistics .................................................................................................................................................19 Open Access ...........................................................................................................................................19 Submission and Fees ..............................................................................................................................20 Pre-submission editing services.........................................................................................................20 Submitting agents ..............................................................................................................................20 Required forms ..................................................................................................................................20 Peer review ........................................................................................................................................21 Revision ..............................................................................................................................................21 In-house production ..........................................................................................................................21 Fees ....................................................................................................................................................21 Editorial policies .....................................................................................................................................23 Manuscript submission & processing ................................................................................................23 External peer review ..........................................................................................................................23 Journal Transfers................................................................................................................................23 Revision ..............................................................................................................................................24 Post-acceptance .................................................................................................................................24 Embargo policy ..................................................................................................................................24 Accelerated publication option .........................................................................................................24 Re-using copyrighted material in Open Access articles.....................................................................24 Disclosure & conflict of interest policy ..............................................................................................24 Future Science Ltd, Unitec House, 2 Albert Place, London, N3 1QB, UK; T: +44 (0)20 8371 6090; F: +44 (0)20 8371 6089; www.future-science.com Future Science Ltd is part of the Future Science Group www.future-science-group.com Version: 17/10/2018 Ethical conduct of research ...............................................................................................................25 Clinical trial registration .....................................................................................................................25 Errata/corrigenda ..............................................................................................................................26 Permissions for reproduced or adapted

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    29 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us